DE2432415A1 - Antibiotica - Google Patents

Antibiotica

Info

Publication number
DE2432415A1
DE2432415A1 DE2432415A DE2432415A DE2432415A1 DE 2432415 A1 DE2432415 A1 DE 2432415A1 DE 2432415 A DE2432415 A DE 2432415A DE 2432415 A DE2432415 A DE 2432415A DE 2432415 A1 DE2432415 A1 DE 2432415A1
Authority
DE
Germany
Prior art keywords
group
acid
compound
mmol
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE2432415A
Other languages
German (de)
English (en)
Inventor
Brian Laundon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of DE2432415A1 publication Critical patent/DE2432415A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
DE2432415A 1973-07-06 1974-07-05 Antibiotica Withdrawn DE2432415A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3227373A GB1472534A (en) 1973-07-06 1973-07-06 7beta-hydroxyiminoacylamido-cephalosporins

Publications (1)

Publication Number Publication Date
DE2432415A1 true DE2432415A1 (de) 1975-01-30

Family

ID=10336049

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2432415A Withdrawn DE2432415A1 (de) 1973-07-06 1974-07-05 Antibiotica

Country Status (16)

Country Link
US (1) US4007174A (enExample)
JP (1) JPS5069093A (enExample)
AT (1) AT335061B (enExample)
BE (1) BE817304A (enExample)
CA (1) CA1055016A (enExample)
CH (1) CH615436A5 (enExample)
DE (1) DE2432415A1 (enExample)
DK (1) DK360874A (enExample)
ES (1) ES428015A1 (enExample)
FR (1) FR2235696B1 (enExample)
GB (1) GB1472534A (enExample)
IE (1) IE39595B1 (enExample)
LU (1) LU70477A1 (enExample)
NL (1) NL7409179A (enExample)
SE (1) SE7408892L (enExample)
ZA (1) ZA744349B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165429A (en) * 1976-06-28 1979-08-21 Yamanouchi Pharmaceutical Co., Ltd. 7α-METHOXY-CEPHALOSPORANIC ACID DERIVATIVES

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4092477A (en) * 1971-05-14 1978-05-30 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
GB1592149A (en) * 1976-10-08 1981-07-01 Fujisawa Pharmaceutical Co 3 7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for preparation thereof
SE439312B (sv) * 1977-03-25 1985-06-10 Roussel Uclaf Sett att framstella nya oximderivat av 3-acetoximetyl-7-aminotiazolylacetamido cefalosporansyra
US5574154A (en) * 1994-09-29 1996-11-12 Alnejma Bulk Pharmaceutical Co. A.B.P.C. Process for the preparation of cephalosporanic compounds
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) * 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
CA2533178C (en) * 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2006528185A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2006528190A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
WO2005016311A1 (en) * 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
AU2004264356B2 (en) * 2003-08-12 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP5686494B2 (ja) * 2003-08-29 2015-03-18 シオノギ インコーポレイテッド 抗生物質製剤、その使用法及び作成方法
EP1663169A4 (en) * 2003-09-15 2010-11-24 Middlebrook Pharmaceuticals In ANTIBIOTICS, ITS USE AND FORMULATION
CA2550983C (en) * 2003-12-24 2013-09-17 Advancis Pharmaceutical Corporation Enhanced absorption of modified release dosage forms
WO2006014427A1 (en) * 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE311519B (enExample) * 1962-12-14 1969-06-16 Astra Ab
GB1208015A (en) * 1967-03-23 1970-10-07 Glaxo Lab Ltd Cephalosporins
US3573294A (en) * 1968-03-14 1971-03-30 Glaxo Lab Ltd 7 - (arylglyoxamido)cephalosporanic acids and their salts and alpha-carbonyl derivatives
GB1433141A (en) * 1972-07-07 1976-04-22 Glaxo Lab Ltd Antibiotics
GB1389194A (en) * 1971-01-29 1975-04-03 Glaxo Lab Ltd Antibiotics

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165429A (en) * 1976-06-28 1979-08-21 Yamanouchi Pharmaceutical Co., Ltd. 7α-METHOXY-CEPHALOSPORANIC ACID DERIVATIVES

Also Published As

Publication number Publication date
DK360874A (enExample) 1975-03-03
GB1472534A (en) 1977-05-04
JPS5069093A (enExample) 1975-06-09
US4007174A (en) 1977-02-08
LU70477A1 (enExample) 1976-05-31
CH615436A5 (en) 1980-01-31
ZA744349B (en) 1975-07-30
AT335061B (de) 1977-02-25
ES428015A1 (es) 1976-07-16
FR2235696B1 (enExample) 1976-12-24
SE7408892L (enExample) 1975-01-07
IE39595L (en) 1975-01-06
NL7409179A (nl) 1975-01-08
IE39595B1 (en) 1978-11-22
AU7072374A (en) 1976-01-08
CA1055016A (en) 1979-05-22
BE817304A (fr) 1975-01-06
FR2235696A1 (enExample) 1975-01-31
ATA556074A (de) 1976-06-15

Similar Documents

Publication Publication Date Title
CH615436A5 (en) Process for the preparation of the syn-isomer or of a mixture of syn- and anti-isomers of novel 7-alpha-substituted 7-beta-acylaminoceph-3-em-4-carboxylic acids
DE2223375A1 (de) Antibiotika und Verfahren zu ihrer Herstellung
DE2204108A1 (de) Cephalosporin- und Penicillin-Antibiotika
DE2439880C3 (de) (6R, 7R)-3-Carbamoyloxymethyl-7- [2-(fur-2-yl)-2methoxyiminoacetamido] -ceph-S-em^carbonsäure und Verfahren zur ihrer Herstellung
DE2744135A1 (de) Cephalosporinderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE2460537C2 (de) 7-β-Acylamido-3-em-4-carbonsäure-Antibiotika
DE2921332A1 (de) Cephalosporinantibiotika
US4074047A (en) 7 2-(Aminocarbonylalkoxyimino)acetamido! derivatives of cephalosporin
DE2514020A1 (de) Acylureidocephalosporine
DE2223667C2 (de) Verfahren zur Herstellung von 8-Oxo-5-thia-1-azabicyclo-[4,2,0]oct-2-en- oder -3-en-Verbindungen
CH618440A5 (enExample)
DE3011038A1 (de) Cephalosporinantibiotika
DE2753182A1 (de) Neue cephalosporine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE2804040A1 (de) Verfahren zur herstellung von cephemverbindungen
DE2943437A1 (de) Cephalosporinverbindungen
CH627758A5 (en) Process for the preparation of the syn isomer or a mixture of the syn isomer and anti isomer of 7beta-acylamidoceph-3-em-4-carboxylic acids with the antibiotic activity
CH638781A5 (de) Verfahren zur herstellung von beta-lactamen.
DE2818025A1 (de) Verfahren zur herstellung von cephemverbindungen
CH625805A5 (enExample)
DE3516777A1 (de) Cephalosporin-antibiotika
US4076936A (en) 7β-(2-Aryl-2-hydroxyiminoacetamido)ceph-3-em-4-carboxylic acids carrying a 7α-lower alkoxy substituent
DE3323462A1 (de) Cephalosporin-antibiotika
AT362500B (de) Verfahren zur herstellung von neuen cephalos- porin-antibiotika
AT371476B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
DE3342317A1 (de) Cephalosporin-antibiotika

Legal Events

Date Code Title Description
8141 Disposal/no request for examination